Cargando...
The effect of tocilizumab on cytokine release syndrome in COVID-19 patients
BACKGROUND: This study was aimed to assess the efficacy and safety of tocilizumab (TCZ) and to investigate the factors related to the progress and mortality of patients with a secondary cytokine release syndrome caused by SARS-CoV-2. METHODS: A retrospective descriptive observational study of hospit...
Guardado en:
| Publicado en: | Pharmacol Rep |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7650573/ https://ncbi.nlm.nih.gov/pubmed/33165762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s43440-020-00186-z |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|